Reciprocally, inhibition of S100A9 reduced transcriptional priming of pyroptosis-associated genes (CASP1, IL-1B, IL-18, and NLRP3) and improved the colony forming capacity of BM-MNCs from patients with MDS. Here, S100A9 is linked to myelodysplastic syndrome.